Inventor · disambiguated record
Gisela Schwab
Also filed as: SCHWAB GISELA
6 granted patents·13 pending applications·23 citations·filing 2003–2024
79Inventor score
Top patents by PatentIndex Score
19 records- 0191US12016854B2Liquid dosage forms to treat cancerEXELIXIS INC·Filed 2022·Granted Jun 25, 2024·1 cites·7 claims
- 0290US11141413B2Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioateEXELIXIS INC·Filed 2017·Granted Oct 12, 2021·8 cites·21 claims
- 0390US7771958B2Method for predicting response to epidermal growth factor receptor-directed therapyAMGEN INC·Filed 2006·Granted Aug 10, 2010·12 cites·14 claims
- 0483US2024316030A1Method of treating cancer and bone cancer painEXELIXIS INC·Filed 2024·Application pending·0 cites
- 0581US11504362B2Liquid dosage forms to treat cancerEXELIXIS INC·Filed 2018·Granted Nov 22, 2022·1 cites·13 claims
- 0678US2024307367A1Liquid Dosage Forms to Treat CancerEXELIXIS INC·Filed 2024·Application pending·0 cites
- 0777US2024350477A1Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N’-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioateEXELIXIS INC·Filed 2023·Application pending·0 cites
- 0876US11198731B2Combinations of cabozantinib and atezolizumab to treat cancerEXELIXIS INC·Filed 2018·Granted Dec 14, 2021·1 cites·17 claims
- 0976US2023149384A1Method of Treating Cancer and Bone Cancer PainEXELIXIS INC·Filed 2022·Application pending·0 cites
- 1073US2022401433A1Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioateEXELIXIS INC·Filed 2022·Application pending·0 cites
- 1169US2023045783A9Method of Treating Renal Cell Carcinoma Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioateEXELIXIS INC·Filed 2021·Application pending·0 cites
- 1267US11504363B2Method of treating cancer and bone cancer painEXELIXIS INC·Filed 2020·Granted Nov 22, 2022·0 cites·11 claims
- 1360US2022056138A1Combinations of Cabozantinib and Atezolizumab to Treat CancerEXELIXIS INC·Filed 2021·Application pending·0 cites
- 1456US2004132097A1Method for predicting response to epidermal growth factor receptor-directed therapyFiled 2003·Application pending·0 cites
- 1554US2010279323A1Method for predicting response to epidermal growth factor receptor-directed therapyAMGEN INC·Filed 2010·Application pending·0 cites
- 1654US2014179736A1Method of Treating Cancer and Bone Cancer PainSCHWAB GISELA·Filed 2012·Application pending·0 cites
- 1753US2023301979A1Combinations for the treatment of cancerEXELIXIS INC·Filed 2021·Application pending·0 cites
- 1849US2004033543A1Treatment of renal carcinoma using antibodies against the EGFrFiled 2003·Application pending·0 cites
- 1947US2019262330A1Method of Treating Hepatocellular Carcinoma Using N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2S)-hydroxybutanedioateEXELIXIS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gisela Schwab files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →